• / Free eNewsletters & Magazine
  • / My Account
Home>Cheap Canadian Drugs: Why?

Cheap Canadian Drugs: Why?

Morningstar Articles

Tue, 26 Aug 2014

Recent mergers of Benchmark BHE and Pemstar, as well as Flextronics FLEX and Solectron SLR, have raised interest in how consolidation could change the competitive landscape of the electronic manufacturing services (EMS) industry. We think consolidation

Related Videos

  1. 5 Funds With a Lot to Gain From M&A

    If deal activity continues, these merger -arbitrage funds could represent great opportunities going forward, says Morningstar's A.J. D'Asaro.

  2. A Low-Expense Alternative to Bonds

    This merger -arbitrage fund has little correlation to the broader equity and fixed-income markets and has a very low expense ratio.

  3. Keep Your Eyes on the Prize in M&A Deals

    With the uptick in merger and acquisition activity, whether it be for tax-inversion or strategic reasons, investors should focus on the target company, which can benefit from the deal immediately.

  4. What Does the Merger With NYSE Mean for ICE's Moat?

    Morningstar's Gaston Ceron addresses the short- and long-term prospects for and opportunities in ICE's takeover of NYSE Euronext.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.